Biogen Inc. (NASDAQ:BIIB) Receives $288.46 Consensus Price T

Biogen Inc. (NASDAQ:BIIB – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty-six brokerages that are covering the stock, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. The average 1 year price objective among […]

Related Keywords

United States , Germany , , Biogen Inc , Financial Group , Barclays , Partners Investment Advisory , Biogen Company Profile , Sequoia Financial Advisors , Investment Advisors , Nasdaq , Quent Capital , Needham Company , Get Free Report , Marketbeat Ratings , Financial Advisors , Street Partners Investment Advisory , Get Free , Biogen Daily ,